Literature DB >> 26161527

Luminescent Rhenium(I) and Iridium(III) Polypyridine Complexes as Biological Probes, Imaging Reagents, and Photocytotoxic Agents.

Kenneth Kam-Wing Lo1.   

Abstract

Although the interactions of transition metal complexes with biological molecules have been extensively studied, the use of luminescent transition metal complexes as intracellular sensors and bioimaging reagents has not been a focus of research until recently. The main advantages of luminescent transition metal complexes are their high photostability, long-lived phosphorescence that allows time-resolved detection, and large Stokes shifts that can minimize the possible self-quenching effect. Also, by the use of transition metal complexes, the degree of cellular uptake can be readily determined using inductively coupled plasma mass spectrometry. For more than a decade, we have been interested in the development of luminescent transition metal complexes as covalent labels and noncovalent probes for biological molecules. We argue that many transition metal polypyridine complexes display triplet charge transfer ((3)CT) emission that is highly sensitive to the local environment of the complexes. Hence, the biological labeling and binding interactions can be readily reflected by changes in the photophysical properties of the complexes. In this laboratory, we have modified luminescent tricarbonylrhenium(I) and bis-cyclometalated iridium(III) polypyridine complexes of general formula [Re(bpy-R(1))(CO)3(py-R(2))](+) and [Ir(ppy-R(3))2(bpy-R(4))](+), respectively, with reactive functional groups and used them to label the amine and sulfhydryl groups of biomolecules such as oligonucleotides, amino acids, peptides, and proteins. Additionally, using a range of biological substrates such as biotin, estradiol, and indole, we have designed luminescent rhenium(I) and iridium(III) polypyridine complexes as noncovalent probes for biological receptors. The interesting results generated from these studies have prompted us to investigate the possible applications of luminescent transition metal complexes in intracellular systems. Thus, in the past few years, we have developed an interest in the cytotoxic activity, cellular uptake, and bioimaging applications of these complexes. Additionally, we and other research groups have demonstrated that many transition metal complexes have facile cellular uptake and organelle-localization properties and that their cytotoxic activity can be readily controlled. For example, complexes that can target the nucleus, nucleolus, mitochondria, lysosomes, endoplasmic reticulum, and Golgi apparatus have been identified. We anticipate that this selective localization property can be utilized in the development of intracellular sensors and bioimaging reagents. Thus, we have functionalized luminescent rhenium(I) and iridium(III) polypyridine complexes with various pendants, including molecule-binding moieties, sugar molecules, bioorthogonal functional groups, and polymeric chains such as poly(ethylene glycol) and polyethylenimine, and examined their potentials as biological reagents. This Account describes our design of luminescent rhenium(I) and iridium(III) polypyridine complexes and explains how they can serve as a new generation of biological reagents for diagnostic and therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26161527     DOI: 10.1021/acs.accounts.5b00211

Source DB:  PubMed          Journal:  Acc Chem Res        ISSN: 0001-4842            Impact factor:   22.384


  57 in total

1.  Affinity-Enhanced Luminescent Re(I)- and Ru(II)-Based Inhibitors of the Cysteine Protease Cathepsin L.

Authors:  Matthew Huisman; Jacob P Kodanko; Karan Arora; Mackenzie Herroon; Marim Alnaed; John Endicott; Izabela Podgorski; Jeremy J Kodanko
Journal:  Inorg Chem       Date:  2018-06-08       Impact factor: 5.165

2.  Visible-to-NIR-Light Activated Release: From Small Molecules to Nanomaterials.

Authors:  Roy Weinstain; Tomáš Slanina; Dnyaneshwar Kand; Petr Klán
Journal:  Chem Rev       Date:  2020-10-30       Impact factor: 60.622

3.  In Vitro Anticancer Activity and in Vivo Biodistribution of Rhenium(I) Tricarbonyl Aqua Complexes.

Authors:  Kevin M Knopf; Brendan L Murphy; Samantha N MacMillan; Jeremy M Baskin; Martin P Barr; Eszter Boros; Justin J Wilson
Journal:  J Am Chem Soc       Date:  2017-09-26       Impact factor: 15.419

4.  Mitochondria-targeted Re(I) complexes bearing guanidinium as ligands and their anticancer activity.

Authors:  Shu-Fen He; Nan-Lian Pan; Bing-Bing Chen; Jia-Xin Liao; Min-Ying Huang; Hai-Jun Qiu; Dong-Chun Jiang; Jun-Jie Wang; Jia-Xi Chen; Jing Sun
Journal:  J Biol Inorg Chem       Date:  2020-10-20       Impact factor: 3.358

5.  Association studies to transporting proteins of fac-ReI(CO)3(pterin)(H2O) complex.

Authors:  Fabricio Ragone; Héctor H Martínez Saavedra; Pablo F García; Ezequiel Wolcan; Gerardo A Argüello; Gustavo T Ruiz
Journal:  J Biol Inorg Chem       Date:  2016-11-04       Impact factor: 3.358

6.  Strongly Reducing, Visible-Light Organic Photoredox Catalysts as Sustainable Alternatives to Precious Metals.

Authors:  Ya Du; Ryan M Pearson; Chern-Hooi Lim; Steven M Sartor; Matthew D Ryan; Haishen Yang; Niels H Damrauer; Garret M Miyake
Journal:  Chemistry       Date:  2017-08-01       Impact factor: 5.236

7.  Targeted photoredox catalysis in cancer cells.

Authors:  Huaiyi Huang; Samya Banerjee; Kangqiang Qiu; Pingyu Zhang; Olivier Blacque; Thomas Malcomson; Martin J Paterson; Guy J Clarkson; Michael Staniforth; Vasilios G Stavros; Gilles Gasser; Hui Chao; Peter J Sadler
Journal:  Nat Chem       Date:  2019-09-23       Impact factor: 24.427

8.  Dinuclear Rhenium Complexes with a Bridging Helicene-bis-bipyridine Ligand: Synthesis, Structure, and Photophysical and Chiroptical Properties.

Authors:  Nidal Saleh; Debsouri Kundu; Nicolas Vanthuyne; Joanna Olesiak-Banska; Anna Pniakowska; Katarzyna Matczyszyn; Victoria Y Chang; Gilles Muller; J A Gareth Williams; Monika Srebro-Hooper; Jochen Autschbach; Jeanne Crassous
Journal:  Chempluschem       Date:  2020-09-23       Impact factor: 2.863

9.  Novel iridium(III) iminopyridine complexes: synthetic, catalytic, and in vitro anticancer activity studies.

Authors:  Deliang Kong; Meng Tian; Lihua Guo; Xicheng Liu; Shumiao Zhang; Yameng Song; Xin Meng; Shu Wu; Lingzi Zhang; Zhe Liu
Journal:  J Biol Inorg Chem       Date:  2018-06-11       Impact factor: 3.358

10.  Resistance-breaking profiling and gene expression analysis on an organometallic ReI-phenanthridine complex reveal parallel activation of two apoptotic pathways.

Authors:  Marcel König; Daniel Siegmund; Lukasz J Raszeja; Aram Prokop; Nils Metzler-Nolte
Journal:  Medchemcomm       Date:  2017-12-20       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.